"As of now, semaglutide is FDA-indicated for slowing chronic kidney disease progression, [but] our results suggest that ...

After clearing Novo Nordisk’s semaglutide treatments Ozempic and Wegovy to reduce the risk of major adverse cardiovascular ...

Eli Lilly and Cipla have joined forces. Cipla will now market Lilly's popular weight-loss drug in India. The medication will ...

Explore the benefits of exercise for kidney disease and type 2 diabetes, plus its challenges and how to incorporate physical ...

REVOLT rounded up what Lizzo, Oprah Winfrey, and more Black celebrities have said about weight loss and how they got there.

On Oct. 30, Eli Lilly will announce third-quarter earnings results that could lift the stock, or pressure it further. Here are three things beyond the headline numbers that investors should know ...

October 30th is the day when Eli Lilly will report its third-quarter results, including sales of its 'superstars' Zepbound ...

Few differences were found for cardiovascular, kidney, and mortality outcomes between liraglutide, semaglutide, and dulaglutide for patients with type 2 diabetes.

Biohacker Bryan Johnson has revealed he 'microdosed' weight-loss medications, despite having under 10 percent body fat. The ...

April Hines has battled with her weight since she was a teenager. But in the past couple of years, she's fallen from 600 pounds to 385, and her blood pressure and blood sugar levels are down, too.

Independence Bank of Kentucky disclosed a purchase of 4,193 shares of Eli Lilly and Company (NYSE: LLY), estimated at $3.12 million based on the average price for the quarter, in its SEC filing for ...

Want to putt like the pros? Ian Poulter shows how a simple string can improve your putting alignment, eye position and stroke.